Immune characterization of pre-clinical murine models of neuroblastoma

Abstract Immunotherapy offers a potentially less toxic, more tumor-specific treatment for neuroblastoma than conventional cytotoxic therapies. Accurate and reproducible immune competent preclinical models are key to understanding mechanisms of action, interactions with other therapies and mechanisms...

Description complète

Enregistré dans:
Détails bibliographiques
Auteurs principaux: Emily R. Webb, Silvia Lanati, Carol Wareham, Alistair Easton, Stuart N. Dunn, Tatyana Inzhelevskaya, Freja M. Sadler, Sonya James, Margaret Ashton-Key, Mark S. Cragg, Stephen A. Beers, Juliet C. Gray
Format: article
Langue:EN
Publié: Nature Portfolio 2020
Sujets:
R
Q
Accès en ligne:https://doaj.org/article/1cd179c8bd0e4a0ba1a1db6fa9ea0186
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires